Dana Investment Advisors, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1427514
BROOKFIELD, WI
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,196,036
New position
Shares Held
36,763
first reported quarter
Ownership
0.036%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#195
of 772 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 94%
Shared 0%
None 6%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $41,564,859 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
387,867 | $12,179,023 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
109,942 | $9,100,998 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
310,768 | $7,648,000 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
36,763 | $6,196,036 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
93,032 | $4,397,622 | |
| 6 | ALKS |
Alkermes plc.
|
38,992 | $2,043,180 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,196,036 | 36,763 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||